BCAB
BioAtla (BCAB)
NASDAQ
$3.60+$0.03 (+0.70%)
Price as of Jun 23, 2026 6:04 PM EDT
  • $6.0M
    Market Cap
  • -81.92%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

N/A
Valuation
BCAB
vs History
vs S&P 500
Profitability
-1
Growth
N/A
Low Earnings Volatility
0

Momentum Score

Score: 65
Valuation
BCAB
vs History
vs S&P 500
3-Month Momentum
-53.74%
12-Month Momentum
-82.44%
3-Month Risk Adjusted Momentum
-102.90%
12-Month Risk Adjusted Momentum
-62.69%

True Yield

N/A
No data found

No data found

Financial Health Score

N/A
Valuation
BCAB
vs History
vs S&P 500
Ohlson's O-Score
1